MedTrace Logo

Cerebral Oximetry for Carotid EEA

NCT02203370 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2015-05-20

No results posted yet for this study

Summary

Aim oft he study is to compare two different devices for cerebral oximetry (FORE-SIGHTTM Monitor (CAS Medical Systems, Branford, Connecticut, USA and INVOSTM Somanetics, Troy, Michigan, USA) in patients undergoing surgical carotid thrombendarterectomy (cTEA) with crossclamped internal carotid artery (ACI). All procedures will be performed in regional anesthesia, therefore the patients will be awake and direct neurological examination during the procedure will be possible, giving information how the drop in cerebral saturation (measured with INVOS and FORESIGHT both on the same patient) correlates with any clinical symptoms.

We expect to see a difference in the total drop and in the delay of the drop of cerebral oxygen saturation, making it possible to detect varieties in specificity and sensitivity of both devices compared to neurologic examination in the awake patient.

Conditions

  • Carotid Thrombendarterectomy
  • Cerebral Oxygenation
  • NIRS
  • Regional Anesthesia

Interventions

DEVICE

NIRS - Near-infrared spectroscopy

Sponsors & Collaborators

  • Salzburger Landeskliniken

    lead OTHER

Principal Investigators

  • Andreas Koköfer, M.D. · UK für Anästhesiologie, LKH Salzburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-07-31
Completion
2016-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02203370 on ClinicalTrials.gov